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The aim of this study was to estimate the evolution of the field of Pharmaceutical Care (PC) by measuring 
the quality and quantity of the scientific production on the topic of PC in Brazil compared to two pioneering 
countries in the field, the United States of America (USA) and Spain. The databases Web of Science, 
Scopus, Medline, Lilacs and SciELO were used as sources for the literature search. Pharmaceutical Care, 
or the appropriate translations, was used as the search term for the literature search, which was limited to 
articles published between 1990 and 2009. A score of quality (SQ) was calculated using variables such 
as impact factor and the frequency of the citations. We included 3265 articles published in 544 journals. 
We found that there was a steady increase in scientific production since 1990 and that the USA had a 
higher quality of scientific production than Spain, whereas the Spain produced the highest quantity of 
articles. In comparison, the Brazilian production of scientific publications on PC is low in terms of both 
quality and quantity but has increased steadily since 2002. Nevertheless, Brazil has not yet reached the 
level of the USA or Spain. In conclusion, Brazil’s scientific production has evolved over the second 
decade studied in this work, with particularly high levels of production in the last five years. However, 
an increase in the quantity and quality of the publications should be encouraged.
Uniterms: Pharmaceutical care/scientific production. Brazil/pharmaceutical care/scientific production. 
Spain/pharmaceutical care/scientific production. United States of America/pharmaceutical care/scientific 
production.
O objetivo deste estudo foi estimar a evolução da área de atenção farmacêutica (AF) através da medição 
da qualidade e quantidade da produção científica na área de AF no Brasil, comparando-a com os países 
pioneiros no ramo: Estados Unidos da América (EUA) e Espanha. Os bancos de dados Web of Science, 
Scopus, Medline, Lilacs e SciELO foram usados como fontes para a pesquisa. AF ou as respectivas 
traduções foram usadas como descritor para a pesquisa bibliográfica sendo incluídos artigos publicados 
no período de 1990 a 2009. A pontuação da qualidade (PQ) foi calculada, utilizando variáveis como 
fator de impacto e frequência das citações. Foram cincluídos 3.265 artigos publicados em 544 revistas. 
Verificou-se um aumento constante na produção científica desde 1990 sendo que os EUA possuíam maior 
qualidade, enquanto a maior quantidade de artigos foi produzida na Espanha. Em comparação, a produção 
brasileira na AF é baixa em qualidade e quantidade, mas tem aumentado desde 2002. Apesar disso, o 
Brasil ainda não atingiu o nível dos EUA ou Espanha. Em conclusão, o Brasil apresentou expressiva 
evolução na última década com maior desenvolvimento nos últimos cinco anos. Entretanto, melhoria 
na quanitdade e qualidade das publicações deve ser incentivada.
Unitermos: Atenção Farmacêutica/produção científica. Brasil/atenção farmacêutica/produção científica. 
Espanha/atenção farmacêutica/produção científica. Estados Unidos da América/atenção farmacêutica/
produção científica.
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INTRODUCTION
Internationally, discussions on the roles and func-
tions assigned to the pharmacist have undergone signifi-
cant transformations and have intensified during the last 
decades of the twentieth century, especially in the United 
States and Europe (Olatunde et al., 2009; Hudgens et al., 
2010). These changes have also influenced Latin America 
and led to a strengthening of the relationship between the 
pharmacist and the patient (Hepler, Grainger-Rousseau, 
1995; Faus-Dáder, Martínez, 1999; Martínez, 1999; 
Penna, 1990; OPAS, 2004).
In Brazil, Pharmaceutical Care (PC) is also becom-
ing an important subject of discussion among researchers, 
policymakers and practitioners (OPAS, 2004). PC is a field 
of practice developed within the context of pharmaceutical 
assistance and includes three main axes: the social need 
for the rational use of medicines, the health care process 
and the medicine user as the main target (Bootman, Har-
rison, Cox, 1997). However, PC is not yet established as 
a routine practice among Brazilian pharmacists (Castro, 
Correr, 2007), even though PC is included in Brazilian 
law (Brasil, 2009).
In the field of scientific research, the scientific 
production is of substantial importance as it is an es-
sential source of public knowledge. In fact, research can 
be viewed as only existing when published or when it is 
presented to the scientific community. Hence, scientific 
journals play a key role in spreading the knowledge gained 
through scientific research (Curty, Boccato, 2005; Araújo, 
Ueta, Freitas, 2005).
Bibliometric studies have been used to evaluate the 
existing scientific knowledge in different areas of study. 
The objective of bibliometrics is to ascertain the scien-
tific and technical activity or to quantify the publications 
focused on the development of more reliable indicators 
(Filippo, Fernandez, 2002).
Therefore, bibliometric analysis has proven to be a 
useful tool for gathering information about the scientific 
activity in a given field or area of research (Iglesias, Rodrí-
guez, Pérez, 2007; Coleman, Schlesselmann, White, 2007; 
Roughead, Semple, Vitry, 2006; Sokar-Todd, Einarson, 
2003; Mayoral, Fernández, Rubio, 2005; Zarate, 1996; 
Witzel, 2009; Silva, 2009; Oshiro, 2008). For example, 
Coleman et al. (2007) used bibliometric analysis to prove 
that faculty members focusing on pharmacy practice in the 
Midwest region of the USA have a more relevant contri-
bution to the biomedical literature than any other faculty 
in that country. The results of this study demonstrated the 
importance of the contributions of pharmacy schools to 
the literature (Coleman et al., 2007). Iglesias, Rodríguez, 
Pérez (2007) assessed the scientific activity in Spain’s 
pharmacist community and observed an increase in the 
number articles published from 2000-2005. This increase 
was attributed to the appearance of specialised journals 
(Iglesias, Rodríguez, Pérez, 2007).
Given the situation described above, it is important 
to examine the publications on PC and identify quantita-
tive and qualitative parameters to objectively evaluate the 
knowledge.
To this end, the aim of the present study was to 
evaluate the quality and quantity of the scientific produc-
tion regarding PC in Brazil and to subsequently compare 
it with those of two countries that have historically exerted 
substantial influence on this subject, the USA and Spain.
MATERIALS AND METHODS 
This study included a search of the publications 
in scientific databases as a way to estimate the scientific 
production in the field of PC.
Inclusion criteria
The estimation of the amount of scientific production 
about PC was based on the selection of articles published 
in indexed scientific journals in the following databases: 
Web of Science, Scopus, Medline, Lilacs and SciELO.
The inclusion criteria used are listed below:
a)  Publications between 1990 and 2009; 
b)  Key words used: pharmaceutical care, atención 
farmacêutica and atenção farmacêutica (in quo-
tation marks to avoid articles not related to PC). 
When searching for papers from a given country, 
the above-mentioned descriptors were added to the 
country name in English, Spanish or Portuguese;
c)  The following selected countries: USA, Spain and 
Brazil. In this search, the limits adopted in (b) were 
not used, so that the articles that included the coun-
try name in the researchers’ affiliations were also 
recovered;
d)  In the Scopus database, the search was limited to the 
following sub-areas: “pharmacology, toxicology and 
pharmacy”, “medicine” and “health professions”.
Exclusion criteria
The results obtained from the searches of the data-
bases were carefully analysed, and scientific studies with 
the following characteristics were excluded:
a) Not in the format of a scientific paper (i.e., books, 
dissertations, abstracts);
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b) Repeated in different searched databases (when 
repeated, each article was counted only once);
c) Not aligning with the PC topic area, as determined 
from the title or abstract.
The type of PC approach described in the article was 
not considered.
Parameters analysed
After gathering the global literature for this study, 
the articles were analysed as a unit and by selected coun-
tries as described below:
a)  Number of papers, publication language and year of 
publication;
b)  The quality of the publication according to the 
journal’s impact factor and the stratum of the journal 
(see below);
c)  Based on the number of papers, the impact factor and 
the relative value assigned to the journal (see below), 
a score of quality (SQ) was calculated to establish a 
parameter of comparison between the countries and 
the overall scientific production.
Qualitative analysis of the scientific production
Impact factor and stratification of journals
The production of scientific publications in the phar-
macy field is evaluated every three years by a Brazilian 
institution, named the Coordenação de Aperfeiçoamento 
de Pessoal de Nível Superior (CAPES), which coordi-
nates the improvement of higher education personnel. 
This institution is a government agency belonging to the 
Education Cabinet, which is responsible for the evaluation 
of the Stricto Sensu Post-graduation programs in Brazil. 
To classify the scientific journals, the CAPES foundation 
stratifies the articles into eight levels. The main stratifica-
tion criterion is the indexing of the journal in the Institute 
for Scientific Information (ISI), Web of Science (Tomson 
Institute) and Scopus (SCImago Research Group, Elsevier 
BV) databases, with the evaluation of the impact factor, 
or the indexing in the MEDLINE, LILACS, International 
Pharmaceutical Abstracts and SciELO databases, without 
evaluation of the impact factor. The journals included in 
this study were classified using the CAPES system with 
slight modifications (Table I).
The field of pharmacy coordination from CAPES 
considers two types of impact factors: the Journal Cita-
tion Reports (JCR), from the ISI base (j-index); and the 
impact factor from the SCImago / Elsevier base (h-index) 
(Ministério da Educação, 2009).
The quality of the scientific production was based 
on the frequency of publication in the different strata and 
on the average of the two types of impact factors analysed.
For purposes of comparison, the simple relative 
frequencies of the strata were grouped as follows: a) 
high qualification stratum (HQ): A1 + A2 + B1 + B2; b) 
intermediate qualification stratum (IQ): B3 and c) low 
qualification stratum (LQ): B4 + B5.
Score of quality 
The SQ of the publications was applied as described 
by Oliveira et al. (2003), with modifications. A SQ was 
calculated for each journal to qualify the scientific journals 
in which PC publications were found. The formula used to 
calculate the score of quality is as follows: SQ = ∑f.w.if; 
SQ = score of quality; f = frequency of article from PC 
field in each journal; w = relative value of the cited refer-
ences; and if = impact factor.
The relative value assignment was based on the 
strata classification of the journals made by CAPES 
(Ministério da Educação, 2009) as follows: A1, relative 
value 10; A2, 8.5; B1, 7; B2, 5; B3, 3; B4, 1.5; B5, 0.5. 
The stratum C was excluded.
The impact factor used for the SQ calculation was 
the j-index. When the publication had only the h-index, it 
was converted to the j-index according to the following 
criteria: a) h-index less than 5 was converted to j-index of 
0.1, b) h-index between 5 and 10 was converted to j-index 
of 0.25, c) h-index between 11 and 20 was converted to 
j-index of 0.5 and d) h-index between 21 and 40 was con-
verted to j-index of 0.75.
To ensure a nonzero score, the j-index value of 0.01 
was assigned for journals classified as B5 (without evalu-
TABLE I - Criteria for stratification according to the j or h impact 
factors. Source: CAPES (2009)
Strata Impact Factor (j or h)
A1 j ≥ 3.0
A2 3.0 > j ≥ 2.3
B1 2.3 > j ≥ 1.6
B2 1.6 > j ≥ 0.8
B3 j < 0.8 or h = 5
B4 h < 5
B5 Indexed in SciELO, MEDLINE, International 
Pharmaceutical Abstracts and LILACS, but not 
indexed in the Institute for Scientific Information 
(ISI), Web of Science (Thomson Institute) or Scopus 
(SCImago Research Group, Elsevier BV)
C Not indexed in the databases listed in the B5 stratum
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ation of the impact factor but indexed in the databases 
considered).
Statistical analysis
The data obtained in the survey were compiled in a 
spread sheet developed using Microsoft Excel software, 
Office version 2007. The compiled data were analysed 
using the Statistical Package Social Science program, ver-
sion 11.5 (SPSS 11.5). Simple relative frequencies were 
calculated for qualitative variables within each group. 
For quantitative variables, one-way analysis of variance 
(ANOVA) and the Fisher post-hoc test were performed 
and the significance level was set at 5%. These quantitative 
data were expressed as the mean and the standard error of 
the mean (S.E.M.).
RESULTS
A total number of 3,459 papers met the inclusion cri-
teria and after applying the exclusion criteria, 194 articles 
were excluded. Three thousand two hundred and sixty five 
papers published about PC in 544 journals between 1990 
and 2009 were analysed (Figure 1). As depicted in Figure 1, 
the publication of papers in the PC field has increased steadi-
ly from 1990 to 2009. This pattern is observed in Spain and 
Brazil, but the publication rates in the USA stabilised after 
2000. The dominant language of the publications was Eng-
lish, representing 74.8% of the publications considered for 
analysis, followed by Spanish (6.5%) and German (5.6%) 
(Figure 2). When each country was considered separately, 
however, the mother language of each country was the most 
common language used in that country’s publications, i.e., 
English for the USA (98%), Spanish for Spain (74.6%) and 
Portuguese for Brazil (54%).
The USA presented the highest value for the h-index 
[40.5(3), p <0.01] followed by WORLD [29.8(2)], Spain 
[29.9(4)] and Brazil [23.2(4)]. The impact factor analysed 
according to the J.C.R. (j-index) shows that the average 
value for Brazil [2.05(0.2), p <0.01] was lower than those 
of the other two selected countries [USA: 3.28(0.4), 
Spain: 2.50(0.3)] and that of the WORLD production 
[2.84(0.3)]. No substantial difference was observed among 
the WORLD, Spanish and USA production levels.
The frequency of the scientific production in the 
USA was higher in the high qualification stratum (HQ) 
and lower in the low qualification stratum (LQ) in relation 
to the frequencies of the WORLD production and the pro-
duction of the other countries (Table II). The Spanish pro-
duction frequency was second to the WORLD production 
frequency, and the Brazilian production frequency was the 
lowest in the HQ stratum among all analysed countries.
The highest SQ were assigned to the publications of 
the world [27.4(5)] and of the USA [29.5(7)]. The Spanish 
production SQ [15.3(3), p<0.01] was lower than the world 
and U.S.A production scores, while the Brazilian produc-
tion score [7.95(2), p<0.01] was the lowest.
The journal with the highest SQ was the Journal of 
TABLE II - Frequency of scientific production by qualification 
stratum. High qualification stratum (HQ): A1 + A2 + B1 + 
B2; intermediate qualification stratum (IQ): B3; and low 
qualification stratum (LQ): B4 + B5
%HQ (n) %IQ (n) %LQ (n)
General 30.5 (166) 30.5 (166) 39.0 (212) 
USA 43.3 (73) 31.4 (53) 25.4 (43)
Spain 34.4 (29) 29.8 (25) 35.8 (30)
Brazil 23.5 (11) 38.3 (18) 38.3 (18)
FIGURE 1 - Evolution of general scientific production and the 
production of each country in five-year intervals.
FIGURE 2 - Language frequencies in the general global 
production (WORLD) of published articles retrieved from 
PUBMED (Medline).
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TABLE IV - Top 20 journals based on the number of papers 
published in the Pharmaceutical Care field
Journal name Number of 
papers
Pharmaceutical Journal 352
Pharmaceutisch Weekblad 153
Pharmaceutical Care España 151
Journal of the American Pharmaceutical 
Association
110
Pharmacy World & Science 85
Pharmaceutical Care and Research 79
The Annals of Pharmacotherapy 78
International Journal of Pharmacy Practice 75
American Journal of Health-System Pharmacy 68
Farmacia Hospitalaria 60
Pharmacy Times 58
Atención Farmacéutica 54
American Journal of Hospital Pharmacy 51
U S Pharmacist 49
Pharmazeutische Industrie 46
Pharmacotherapy 44
Pharmazeutische Zeitung 43
Deutsche Apotheker Zeitung 43
Pharmacy Practice 40
American Pharmacy 37
TABLE III - Top 20 journals based on the Score of Quality
Journal name Score of Quality 
(SQ)
Journal of the American Medical 
Association (JAMA)
1,585.0
The Annals of Pharmacotherapy 1,497.7
Pharmacotherapy 945.1
American Journal of Health-System 
Pharmacy
839.2
Pharmacoepidemiology and Drug safety 705.7
Pharmacy World & Science 604.5
Pharmaceutical Journal 528.0
Annals of Internal Medicine 350.0
Clinical Therapeutics 306.4
Nature Reviews Drug Discovery 286.9
Archives of Internal Medicine 273.3
British Medical Journal 256.5
British Journal of Clinical Pharmacology 218.9
Journal of Clinical Pharmacy and 
Therapeutics
196.6
American Journal of Medicine 153.1
Journal of the American Geriatrics Society 152.2
Lancet Oncology 132.0
Current Pharmaceutical Design 131.9
Patient Education and Counseling 124.3
Journal of General Internal Medicine 115.6
the American Medical Association (JAMA) (SQ = 1,585), 
in which five articles meeting the selection criteria were 
published. This journal has the maximum relative value 
and a J.C.R. of 31.7. The journal with the highest number 
of papers published in the PC field was the Pharmaceuti-
cal Journal, with 352 articles. Table III presents the top 
20 journals based on their SQ, and Table IV presents the 
top 20 journals based on the number of articles published.
DISCUSSION
The present study shows an increase in the number 
of articles in the PC field published in the period analysed. 
This finding indicates that this field of knowledge has 
been growing since 1990. An evaluation of the scientific 
literature on Pharmaceutical Care conducted by Silva 
(2009) from 1968 to 2008 also showed that the number of 
articles about PC has increased since 1990. The year 1990 
was chosen as the first year of analysis because in this year, 
PC practice became a subject of global interest, which was 
the result of the publication of the classic paper by Hepler 
and Strand (Hepler, Strand, 1990). The data were limited 
to peer-reviewed papers, which represent the prevailing 
method of disseminating scientific knowledge (Narvai, 
Almeida, 1998). Despite these limitations, the articles 
selected for analysis represent an important opportunity 
to track the trends in research in the field of PC (Narvai, 
Almeida, 1998).
The quality of the journals retrieved was evaluated 
using the stratification levels recommended by the Phar-
macy area of CAPES (Ministério da Educação, 2009), the 
impact factor and the SQ. The stratification of the journals 
by CAPES is based on the quality criteria described in the 
methods section, and the publications in the higher strata, 
together with the number of articles published, represent 
the productivity indicators used to evaluate research in all 
fields of knowledge. For this reason, the relative values 
assigned to journals by the pharmacy area from CAPES 
were used to calculate the SQ. This methodology also 
justifies the exclusion of stratum C of the CAPES classi-
fication from consideration in this study, because stratum 
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C includes articles indexed in databases other than those 
included in the inclusion criteria and also because it de-
scribes a relative value of “zero” (Ministério da Educação, 
2009).
The scientific production of the three countries anal-
ysed followed different patterns of evolution. These differ-
ences should reflect the evolution of the PC field in these 
countries. In the first decade considered (1990-1999), the 
production in the USA was markedly greater than that in 
other countries. The American scientific production was 
most likely stimulated by the hallmark American study of 
Hepler and Strand (1990), from which the term Pharma-
ceutical Care originates. Therefore, the discussion of PC in 
the USA would benefit from an analysis that begins before 
1990. In the second decade considered (2000-2009), the 
number of articles produced in the USA remained stable. 
This change may be attributable to an increase in the qual-
ity, rather than the quantity, of the articles published in the 
USA during this time, as shown by a higher frequency in 
the HQ stratum and a lower frequency in the LQ stratum 
compared to other countries.
Spain showed incremental increases in its frequency 
of publication from 1990 to 2009, with the highest fre-
quency occurring between 2000 and 2004. The growth in 
this particular period could possibly be explained by the 
origin of the PC field in that country, which was marked 
by the introduction of Dáder’s method of Pharmaceutical 
Care that was officially released in 2000 (Faus-Dáder, 
2000), the publication of the Consensus of Pharmaceutical 
Care by the Spanish Cabinet of Health in 2001 (España, 
2001) and the Second Consensus of Granada on Drug 
Related Problems in 2002 (Panel de Consenso Ad Hoc, 
2002). The Spanish translation of the classic work of 
Hepler and Strand (1999) may also have contributed to 
increasing the dissemination of knowledge about PC in 
Spain, which led to the increase in the frequency of sci-
entific production in this field.
Brazilian production increased from 1990 to 2009, 
although the overall number of publications is lower 
than those of the USA and Spain. In the first analysed 
decade, only two articles could be recovered that met the 
inclusion criteria. In 2002, recommendations from the 
Brazilian Consensus on Pharmaceutical Care stimulated 
the practice of PC in Brazil, which is likely the reason 
for the increase of the production in Brazil in the second 
decade considered. Recently, the National Health Surveil-
lance Agency of Brazil (Agência Nacional de Vigilância 
Sanitária - ANVISA) has instituted a law concerning PC 
practice in pharmacies (Brasil, 2009).
Some studies about Brazilian scientific production 
on PC have shown a remarkable trend in the production 
in the PC field since 2000 (Witzel, 2009; Oshiro, Castro, 
2008; Pereira, Freitas, 2008). However, those studies 
include other types of scientific production, such as un-
indexed articles, abstracts, and books. The present study 
focused on articles published in qualified journals that are 
at least indexed in the databases listed by CAPES (Minis-
tério da Educação, 2009).
It is worth mentioning that the recommendations of 
the Brazilian Consensus on Pharmaceutical Care (Con-
senso Brasileiro de Atenção Farmacêutica – Proposta, 
2002) have most likely been an important instrument for 
boosting PC in Brazil. Brazilian production has increased 
20-fold between 2000, when approximately 4 articles were 
retrieved, and 2009. Witzel (2009) also retrieved only a 
few articles about PC in indexed journals before 2002. 
An increase in the Brazilian production of publications on 
PC was also observed beginning in 2006 (Witzel, 2009; 
Oshiro, Castro, 2008; Ferreira, 2008).
Ferreira (2008) still highlights that a significant 
number of articles in the area of PC have been submitted 
for publication in the Brazilian Journal of Pharmaceuti-
cal Sciences. This fact reflects the structuring of this area 
in this country, as well as the trends in education based 
on the new curriculum guidelines, in which PC has been 
inserted as a compulsory subject in the curricula of most 
pharmacy courses.
The dominant language of publications was Eng-
lish. A similar result was also observed by Silva (2009). 
English seems to be the language that provides the highest 
visibility for publications (Silva, 2009).
When examining individual countries, the publica-
tions are principally in the mother language of that country, 
i.e., English for the USA (98%), Spanish for Spain (74.6%) 
and Portuguese for Brazil (54%). This trend can put Bra-
zilian scientific production at a disadvantage by reducing 
its impact in the international community, as Portuguese 
corresponded to only 1.3% of the total publications. How-
ever, the frequency of English in the Brazilian production 
was relatively high (49%), which may reflect the tendency 
of the Brazilian researchers to use English to improve the 
visibility of their publications. This trend can be clearly 
observed due to the fact that many of the journals indexed 
in the SciELO database (Latin America) are either com-
pletely in English or are in English and another language, 
with the intention of increasing the visibility of these 
publications in the international community (Silva, 2009).
Brazilian participation in HQ production is less fre-
quent than that of other countries. This finding could be a 
result of the journals in which Brazil publishes its studies, 
which have a lower average impact factor than the journals 
selected by the other countries. 
Scientific production in pharmaceutical care: comparison between Brazil, USA and Spain 45
The difference in the results between the h and j 
indexes may result from the fact that much of the Brazil-
ian production is in the B3 stratum, which in many cases 
presents an h-index but not a j-index evaluation. This may 
have led to an overestimation of the Brazilian production 
impact factor.
The scores of quality allow for equal comparision 
and still consider the frequency of publication in a certain 
journal and the relative value assigned by the Pharmacy 
area of CAPES (Ministério da Educação, 2009). This 
calculation was performed to better evaluate the quality 
of journals in the area of PC and, hence, the WORLD 
production and the production of selected countries. 
The score of quality indicates that the USA has the 
best quality of publications, although the USA is below 
Spain in terms of quantity. Although the USA production 
did not increase in terms of quantity in the last decade, it 
is likely that there is a trend towards quality over quantity 
in the publications in this field. In fact, three of the five 
relevant articles published in JAMA and approximately 
half of those published in The Annals of Pharmacotherapy 
came from the USA.
It can also be observed that the number of articles 
seems to be the main factor influencing the difference in 
SQ between Spain and Brazil, given that the JCR values 
of the two countries, although significantly different, are 
still very close.
CONCLUSION
The results of this study indicate that the scientific 
production in the area of Pharmaceutical Care around the 
world has been steadily evolving since 1990 although it 
follows different patterns of evolution in terms of quality, 
quantity and time. The American production is of the high-
est quality, whereas Spain published the greatest number 
of papers among the three analysed countries. Brazil’s 
evolution showed impressive development over the last 
five years of the analysed time period. In comparison to the 
other countries, the Brazilian production on PC is low and 
an increase in the quantity and quality of the publications 
in Brazil should be encouraged.
LIMITATIONS OF THE STUDY
We calculated an SQ with the aim to standardise the 
evaluation of the quality of the journals. However, our 
study did not present a qualitative analysis of the objective, 
methods and results of each retrieved article, and these 
components are not reflected in the SQ formula. Therefore, 
it is possible that a well-designed study has been published 
in a journal with a low SQ and vice-versa, and readers 
should therefore not always consider a journal with no im-
pact factor or a low SQ as a low quality scientific journal.
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